Viking Therapeutic's Oral Weight-Loss Drug Impresses, but Shares Drop 6%
Viking Therapeutics (VKTX.US) weight loss drug emerges as a dark horse, challenging the dominance of the 'Norlevo Brothers'.
Data released earlier on Monday by viking therapeutics shows that novo-nordisk a/s and eli lilly and co, currently dominating the obesity drug field, may face fierce competition in the future.
Big Pharma's Obesity Bonanza Faces New Tests -- Heard on the Street -- WSJ
Why Viking Therapeutics Stock Plummeted After Soaring Today
Health Care Down as GLP-1 Enthusiasm Wanes -- Health Care Roundup
US stocks closed: Trump, Harris concept stocks rose together, Chinese concept stocks remained stable and rose.
1. The market is filled with a wait-and-see attitude, with all three major indexes collectively falling. 2. Trump's media technology group rebounded after hitting bottom. 3. Photovoltaic and clean energy concept stocks strengthened collectively. 4. Reports claim that Nvidia will distribute Super Micro Computer orders to other suppliers.
